| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |